Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis
Authors:
- Veronica MiguelVMVeronica Miguel
- Jessica TituanaJTJessica Tituana
- J.Ignacio HerreroJHJ.Ignacio Herrero
- Laura HerreroLaura Herrero
- Dolors SerraDolors Serra
- Paula CuevasPCPaula Cuevas
- Coral BarbasCBCoral Barbas
- Diego Rodriguez-PuyolDRDiego Rodriguez-Puyol
- Laura Marquez-ExpositoLMLaura Marquez-Exposito
- Marta Ruiz-OrtegaMarta Ruiz-Ortega
- Carolina CastilloCCCarolina Castillo
- Xin ShengXSXin Sheng
Preprint
Abstract
Chronic kidney disease (CKD) remains a major epidemiological, clinical and biomedical challenge. During CKD, renal tubular epithelial cells (TECs) suffer a persistent inflammatory and profibrotic response. Fatty acid oxidation (FAO), the main source of energy for TECs, is reduced in kidney fibrosis and contributes to its pathogenesis. To determine if FAO gain-of-function (FAO-GOF) could protect from fibrosis, we generated a conditional transgenic mouse model with overexpression of the fatty acid shuttling enzyme carnitine palmitoyl-transferase 1 A (CPT1A) in TECs. Cpt1a knock-in (CPT1A KI) mice subjected to three different models of renal fibrosis (unilateral ureteral obstruction, folic acid nephropathy-FAN and adenine induced nephrotoxicity) exhibited decreased expression of fibrotic markers, a blunted pro-inflammatory response and reduced epithelial cell damage and macrophage influx. Protection from fibrosis was also observed when Cpt1a overexpression was induced after FAN. FAO-GOF restituted oxidative metabolism and mitochondrial number and enhanced bioenergetics increasing palmitate oxidation and ATP levels, changes also recapitulated in TECs exposed to profibrotic stimuli. Studies in patients evidenced decreased CPT1 levels and increased accumulation of short and middle chain acyl-carnitines, reflecting impaired FAO in human CKD. We propose that strategies based on FAO-GOF may constitute powerful alternatives to combat fibrosis inherent to CKD. Graphical Overexpression of CPT1A impedes tubular epithelial renal cell dedifferentiation and a pro-fibrotic phenotype by restoring mitochondrial metabolic bioenergetics.Keywords
All Related Versions
- Published version: Journal of Clinical Investigation, 131 (5).
This publication has 41 references indexed in Scilit:
- Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and FibrosisCell Metabolism, 2019
- The Emerging Role of Mitochondrial Targeting in Kidney Disease2016
- The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney DiseaseCurrent Diabetes Reports, 2015
- Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis developmentNature Medicine, 2014
- Slowing progression of chronic kidney diseaseKidney International Supplements, 2013
- Risk factors for chronic kidney disease: an updateKidney International Supplements, 2013
- Differentiated kidney epithelial cells repair injured proximal tubuleProceedings of the National Academy of Sciences, 2013
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Mouse models to study kidney development, function and diseaseCurrent Opinion in Nephrology and Hypertension, 2011
- The origin of interstitial myofibroblasts in chronic kidney diseasePediatric Nephrology, 2011